PMCB CIK: 1157075

PharmaCyte Biotech, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
(positive)
millions USD
FY22:
–
FY23:
–
FY24:
–
FY25:
–
FY26:
–
(positive)
Change from FY22 to FY26
millions USD
FY22:
−4.39
FY23:
−6.46
FY24:
−8.52
FY25:
−4.38
FY26:
−6.85
(positive)
Change from FY22 to FY25
millions USD
FY22:
−4.24
FY23:
−6.46
FY24:
–
FY25:
−38.0
FY26:
–
(positive)
Change from FY22 to FY25
millions USD
FY22:
−4.24
FY23:
−4.32
FY24:
–
FY25:
30.7
FY26:
–
(positive)
Change from FY22 to FY26
millions USD
FY22:
−4.24
FY23:
−4.32
FY24:
0.33
FY25:
30.7
FY26:
−19.4

All amounts in millions USD Data sources:SEC EDGARTwelve Data